Back to Journals » OncoTargets and Therapy » Volume 17

Hsa_circRNA_000166 Promotes Cell Proliferation, Migration and Invasion by Regulating miR-330-5p/ELK1 in Colon Cancer [Retraction]

Authors Zhao G, Dai GJ

Received 28 March 2024

Accepted for publication 28 March 2024

Published 3 April 2024 Volume 2024:17 Pages 285—286

DOI https://doi.org/10.2147/OTT.S471178



Zhao G, Dai GJ. Onco Targets Ther. 2020;13:5529-5539.

We, the Editors and Publisher of OncoTargets and Therapy, have retracted the following article.

Following publication of the article, concerns were raised about the duplication of images from Figures 4 with images from other unrelated articles. Specifically,

  • Images for Figure 4D have been duplicated with images for Figures 4E from Zhang Y, Yang Y, Zhang Y, Liu Z. lncRNA ST8SIA6‑AS1 facilitates proliferation and invasion in liver cancer by regulating miR‑142‑3p. Experimental and Therapeutic Medicine. 2021;22:1348. https://doi.org/10.3892/etm.2021.10783 and Li M, Song SW, Ge Y, Jin JY, Li XY, Tan XD. The Ras-ERK signaling pathway regulates acetylated activating transcription factor 2 via p300 in pancreatic cancer cells. Ann Transl Med. 2020;8(19):1234. https://doi.org/10.21037/atm-20-5880.

The authors did not respond to our queries and were unable to provide an explanation for the duplicated images or provide data for the study. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article and the authors were notified of this.

We have been informed in our decision-making by our editorial policies and COPE guidelines.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.


This retraction relates to this paper


Creative Commons License © 2024 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.